Posts Tagged 'cancer drug'

GTx Drug to Treat Muscle Wasting Fails to Meet Late-Stage Requirements

A drug designed to treat cancer-induced muscle wasting has failed its late-stage development trials. A story by Reuters reports that the drug, named enobosarm, did not meet its requirements to improve body mass and physical function in cancer patients. The manufacturer, GTx Inc, will therefore not be receiving FDA approval for its new drug.

Enobosarm was tested on about 650 patients with non-small cell lung cancer and did not meet any of the pre-specified requirements. ...

continue reading...